Profile
Jennifer Robinson formerly worked at Dyax Corp., as Senior Director-Investor Relations from 2014 to 2016, Ra Pharmaceuticals, Inc., as Senior Director-Investor Relations, resTORbio, Inc., as Senior Director-Investor Relations, Deciphera Pharmaceuticals, Inc., as Vice President-Investor Relations & Communications, and Verve Therapeutics, Inc., as Vice President-Investor Relations & Communications.
Ms. Robinson received her undergraduate degree from Dartmouth College.
Former positions of Jennifer Robinson
| Companies | Position | End |
|---|---|---|
| VERE THER | Investor Relations Contact | 24/07/2025 |
| DYAX CORP. | Investor Relations Contact | 31/03/2016 |
| RA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
| DECIPHERA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
| ADICET BIO, INC. | Investor Relations Contact | - |
Training of Jennifer Robinson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Dyax Corp.
Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
Ra Pharmaceuticals, Inc.
Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of glomerulonephritis, kidney disease and cardiovascular disease | Health Technology |
Dartmouth College
Dartmouth College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
resTORbio, Inc.
resTORbio, Inc. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
Deciphera Pharmaceuticals, Inc.
Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
Verve Therapeutics, Inc.
Verve Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicines to treat patients with cardiovascular disease | Health Technology |
- Stock Market
- Insiders
- Jennifer Robinson
















